Pharmacology

Help for Sarcoidosis-Related Fatigue

More than half of sarcoidosis patients say fatigue is debilitating, and most studies of sarcoidosis identify fatigue as a major cause of impaired quality of life. Armodafinil significantly reduces fatigue in patients with sarcoidosis, according to a small study by researchers from the University of Cincinnati in Cincinnati, Ohio, and Harvard Medical School in Boston, Massachusetts.


 

Recommended Reading

Is same-day discharge after PCI safe?
Federal Practitioner
Brain Metastasis
Federal Practitioner
Delta NT-proBNP: Better Marker of Neuroendocrine Pathways Blockade in Decompensated Congestive Heart Failure?
Federal Practitioner
Steroid-Induced Myopathy and Associated Postoperative Complications
Federal Practitioner
Mental Illness and Smoking; Hypervigilance and PTSD Risk
Federal Practitioner
Helping Women Stay Healthy; Coping With MS; E-Books for Patients With Cancer
Federal Practitioner
Cardiovascular Disease Is a Risk Factor for Hip Fracture; Does Frailty Protect Against Cancer?; Choosing the Best Catheter for the Patient
Federal Practitioner
OnabotulinumtoxinA for Bladder Problems; Older Cancer Patients Not Getting Full Treatment; Vitamin B Reduces Diabetic Neuropathy
Federal Practitioner
Understanding Heart Failure
Federal Practitioner
Meetings & Events
Federal Practitioner